A Study to Evaluate the Efficacy and Safety of Anti-PD-1 Antibody AK105 in Patients With Selected Advanced Solid Tumors

Clinical trial NCT04172506 · COMPLETED

Trial details

NCT number: NCT04172506
Sponsor: Akeso
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Lung Cancer HCC

Start date: 2019-09-10
Primary completion: 2021-12-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.